Novo Nordisk stock target raised at UBS ahead of Wegovy Pill launch [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
The bank reiterated a Neutral rating on the stock. “We are seeing significant focus on initial Rx data for the Wegovy pill, but the data is unlikely to fully reflect the launch,” analysts led by Matthew Weston said in a note. They emphasized that initial data will not capture NovoCare and telehealth channels until later in the first quarter, which represent the largest sources of cash-pay prescriptions. Analysts said channel checks also suggest that early insurance coverage is constrained by prior authorisations and step edits, limiting the pace of uptake in the first weeks. Based on comparisons with earlier obesity drug launches, UBS does not expect an immediate surge in prescriptions. It pointed out that both Wegovy and Eli Lilly's Zepbound took several weeks before reaching more meaningful prescription volumes. The analysts forecast first-quarter Wegovy pill prescriptions of around 400,000, which they said is comparable to the Zepbound launch by volume and “significantly
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk Jumps on Higher Wegovy Dose [Yahoo! Finance]Yahoo! Finance
- The Fastest Path To Greenland Runs Through Novo Nordisk [Forbes]Forbes
- Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more [CNBC]CNBC
- Fat jabs could lead to cheaper air fares [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website